P675: IMATINIB THERAPY IN PREVIOUSLY UNTREATED CHRONIC MYELOID LEUKAEMIA PATIENTS WHO ACHIEVE MMR AFTER 12 MONTHS THERAPY WITH DASATINIB: A STRATEGY TO AVOID LONG TERM OFF TARGET TOXICITY

• Lucy Pemberton,
• Katrina Sharples,
• Yujin Kim,
• Emma-Jane Mcdonald,
• Humphrey Pullon,
• Bart Baker,
• Merit Hanna,
• Gordon Royle,
• Shahidul Islam,
• Victoria Campion,
• Michael Findlay,
• Peter Browett

Affiliations

Lucy Pemberton

1 Te Whatu Ora Southern, Dunedin, New Zealand

Katrina Sharples

2 University of Otago, Dunedin, New Zealand

Yujin Kim

3 Cancer Trials New Zealand, Auckland, New Zealand

Emma-Jane Mcdonald

5 Te Whatu Ora, Christchurch, New Zealand

Humphrey Pullon

6 Pathlab Tristram St, Hamilton, New Zealand

Bart Baker

7 Te Whatu Ora, Palmerston North, New Zealand

Merit Hanna

8 Te Whatu Ora, Auckland

Gordon Royle

8 Te Whatu Ora, Auckland

Shahidul Islam

9 Te Whatu Ora, Hamilton, New Zealand

Victoria Campion

10 Te Whatu Ora, Wellington, New Zealand

Michael Findlay

3 Cancer Trials New Zealand, Auckland, New Zealand

Peter Browett

4 University of Auckland, Grafton Campus, Auckland, New Zealand